发明名称 |
Process for producing an iron-dextran compound, iron-dextran compound produced according to said process, pharmaceutical composition for prophylaxis or treatment of iron-deficiency and use of said compound for the preparation of a parenterally administrable pharmaceutical composition |
摘要 |
In a process for producing an iron-dextran compound for use in parenteral treatment of iron-deficiency in humans or animals a stable compound of desired relatively low molecular weight is obtained by using first hydrogenation and then oxidation to convert reducing terminal groups on the dextran molecules before reaction with the iron. By varying the ratio of hydrogenated groups to oxygenated groups the average molecular weight of the resulting iron-dextran compound can be varied.
|
申请公布号 |
US2003083310(A1) |
申请公布日期 |
2003.05.01 |
申请号 |
US20020300032 |
申请日期 |
2002.11.20 |
申请人 |
PHARMACOSMOS HOLDING A/S |
发明人 |
ANDREASEN HANS BERG;CHRISTENSEN LARS |
分类号 |
A61K9/14;A61K9/08;A61K31/295;A61K31/715;A61K31/721;A61K47/12;A61K47/48;A61P3/02;A61P7/06;C08B37/00;C08B37/02;(IPC1-7):C08B37/02 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|